Department of Clinical Psychology and Psychotherapy, Institute of Psychology, Goethe University Frankfurt, Frankfurt Main, Germany.
Psychother Psychosom. 2013;82(4):213-20. doi: 10.1159/000348450. Epub 2013 May 22.
The feeling of being contaminated (FBC) is a common phenomenon in survivors of childhood sexual abuse (CSA) suffering from posttraumatic stress disorder (PTSD). Thus far, this symptom has been neglected in research and therapy. For this reason, we developed Cognitive Restructuring and Imagery Modification (CRIM), a two-session treatment (lasting 90 and 50 min) that specifically targets the FBC. The present study examined the efficacy of the treatment.
Thirty-four women with CSA-related PTSD (mean age = 37 years) were randomized to either the CRIM group or a waitlist control group. Primary outcomes were intensity, vividness, and uncontrollability of the FBC, associated distress, and PTSD symptoms, which were assessed using the Clinician-Administered PTSD Scale and the Posttraumatic Diagnostic Scale. Outcomes were measured pre- and posttreatment, and at the 4-week follow-up. (M)ANOVAs were used to compare improvements across conditions.
All FBC scores yielded a greater reduction in the CRIM group than the waitlist control (WL) group. Between-group effect sizes at follow-up were large and highly significant (intensity: d = 1.52, p < 0.001; vividness: d = 1.28, p < 0.001; uncontrollability: d = 1.77, p < 0.001; distress: d = 1.80, p < 0.001). PTSD symptoms also yielded a greater reduction in the CRIM group than the WL group, with large between-group effect sizes (Clinician-Administered PTSD Scale: d = 0.93, p < 0.001).
Our findings support the efficacy of the newly developed CRIM in reducing the FBC and PTSD symptoms in adult survivors of CSA.
被污染感(FBC)是遭受创伤后应激障碍(PTSD)的儿童性虐待幸存者的常见现象。迄今为止,该症状在研究和治疗中被忽视。因此,我们开发了认知重构和意象修改(CRIM),这是一种针对 FBC 的两阶段治疗(持续 90 分钟和 50 分钟)。本研究检验了该治疗的疗效。
34 名与 CSA 相关的 PTSD 成年幸存者(平均年龄=37 岁)被随机分配到 CRIM 组或等待名单对照组。主要结果是 FBC 的强度、生动性和不可控性、相关痛苦和 PTSD 症状,这些都使用临床医生管理的 PTSD 量表和创伤后诊断量表进行评估。结果在治疗前、治疗后和 4 周随访时进行测量。(M)ANOVA 用于比较各条件下的改善情况。
CRIM 组的所有 FBC 评分均较等待名单对照组(WL 组)有更大的降低。随访时的组间效应大小较大且具有高度显著性(强度:d=1.52,p<0.001;生动性:d=1.28,p<0.001;不可控性:d=1.77,p<0.001;痛苦:d=1.80,p<0.001)。CRIM 组的 PTSD 症状也较 WL 组有更大的降低,且组间效应大小较大(临床医生管理的 PTSD 量表:d=0.93,p<0.001)。
我们的发现支持新开发的 CRIM 在减少 CSA 成年幸存者的 FBC 和 PTSD 症状方面的有效性。